Fortress Biotech Inc

10 مارس 2025، 02:12 ص UTC

Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY

10 مارس 2025، 02:12 ص UTC

Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY

10 مارس 2025، 02:11 ص UTC

Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY

10 مارس 2025، 02:11 ص UTC

Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY

10 مارس 2025، 02:10 ص UTC

Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY

10 مارس 2025، 02:10 ص UTC

Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT

10 مارس 2025، 02:06 ص UTC

Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT